Casey Woodring Analyst PerformanceAnalyst at JPMorgan Chase & Co.Casey Woodring is a stock analyst at JPMorgan Chase & Co. in the healthcare sector, covering 22 publicly traded companies. Over the past year, Casey Woodring has issued 53 stock ratings, including buy, hold, and sell recommendations. While full access to Casey Woodring's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Casey Woodring's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings58 Last 1 YearsBuy Recommendations50.00% 29 Buy RatingsCompanies Covered22 Unique Companies Ratings Distribution58RatingsDistribution of strong buy, buy, hold, and sell ratings by Casey Woodring.RatingPercentageCount Strong Buy0.0%0 ratings Buy50.0%29 ratings Hold44.8%26 ratings Sell5.2%3 ratingsOut of 58 total stock ratings issued by Casey Woodring at JPMorgan Chase & Co., the majority (50.0%) have been Buy recommendations, followed by 44.8% Hold and 5.2% Sell.Best & Worst CallsBest Call00.0%ICLRFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ63.6% of companies on NASDAQ14 companiesNYSE36.4% of companies on NYSE8 companiesCasey Woodring, an analyst at JPMorgan Chase & Co., currently covers 22 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare22 companies100.0%Casey Woodring of JPMorgan Chase & Co. specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageLIFE SCIENCES TOOLS & SERVICES16 companies72.7%HEALTHCARE PROVIDERS & SERVICES3 companies13.6%HEALTHCARE EQUIPMENT & SUPPLIES2 companies9.1%BIOTECHNOLOGY1 company4.5% Casey Woodring's Ratings History at JPMorgan Chase & Co. Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsILMNIllumina7/31/2026Boost Price Target$201.13$230.00Overweight$0.0000.00% ROIGHGuardant Health7/31/2026Boost Price Target$160.63$195.00Overweight$0.0000.00% ROIIQVIQVIA7/29/2026Boost Price Target$246.43$285.00Overweight$0.0000.00% ROIRGENRepligen7/29/2026Boost Price Target$142.32$175.00Overweight$0.0000.00% ROIQDELQuidelOrtho7/1/2026Boost Price Target$19.08$12.00Underweight$0.0000.00% ROIICLRIcon6/25/2026Boost Price Target$163.64$155.00Neutral$0.0000.00% ROIILMNIllumina6/10/2026Upgrade$160.03$185.00Overweight$0.0000.00% ROIBRKRBruker6/8/2026Boost Price Target$57.35$65.00Overweight$0.0000.00% ROIICLRIcon5/29/2026Boost Price Target$135.08$130.00Neutral$0.0000.00% ROIICLRIcon5/18/2026Lower Price Target$116.71$120.00Neutral$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ALMRAlamar Biosciences5/12/2026Initiated Coverage$23.88$30.00Overweight$0.0000.00% ROITXG10x Genomics5/12/2026Boost Price Target$21.00$20.00Neutral$0.0000.00% ROIMTDMettler-Toledo International5/11/2026Lower Price Target$1,087.06$1,200.00Neutral$0.0000.00% ROINTRANatera5/8/2026Boost Price Target$195.54$265.00Overweight$0.0000.00% ROIGHGuardant Health5/8/2026Boost Price Target$92.05$135.00Overweight$0.0000.00% ROICAICaris Life Sciences5/8/2026Lower Price Target$16.08$30.00Overweight$0.0000.00% ROIBLLNBilliontoone5/7/2026Boost Price Target$90.47$125.00Overweight$0.0000.00% ROIRVTYRevvity5/6/2026Lower Price Target$99.50$90.00Neutral$0.0000.00% ROIRGENRepligen5/6/2026Lower Price Target$125.76$165.00Overweight$0.0000.00% ROIWATWaters5/6/2026Boost Price Target$349.91$345.00Neutral$0.0000.00% ROIILMNIllumina5/1/2026Boost Price Target$134.08$125.00Neutral$0.0000.00% ROIQGENQiagen4/29/2026Lower Price Target$33.61$45.00Overweight$0.0000.00% ROICRLCharles River Laboratories International4/13/2026Lower Price Target$178.11$160.00Neutral$0.0000.00% ROIRVTYRevvity3/31/2026Lower Price Target$86.45$96.00Neutral$0.0000.00% ROITEMTempus AI2/25/2026Lower Price Target$53.74$60.00Neutral$0.0000.00% ROIGHGuardant Health2/20/2026Boost Price Target$100.99$130.00Overweight$0.0000.00% ROIQGENQiagen2/6/2026Boost Price Target$51.13$60.00Overweight$0.0000.00% ROIIQVIQVIA2/6/2026Lower Price Target$187.50$225.00Overweight$0.0000.00% ROIILMNIllumina2/6/2026Lower Price Target$119.72$120.00Neutral$0.0000.00% ROITEMTempus AI12/15/2025Lower Price Target$69.96$80.00Neutral$0.0000.00% ROINTRANatera12/15/2025Boost Price Target$229.33$260.00Overweight$0.0000.00% ROIILMNIllumina12/15/2025Boost Price Target$134.71$130.00Neutral$0.0000.00% ROIGHGuardant Health12/15/2025Boost Price Target$103.91$120.00Overweight$0.0000.00% ROICRLCharles River Laboratories International12/15/2025Boost Price Target$197.09$190.00Neutral$0.0000.00% ROIBRKRBruker12/15/2025Boost Price Target$45.61$55.00Overweight$0.0000.00% ROIBLLNBilliontoone12/10/2025Lower Price Target$103.51$145.00Overweight$0.0000.00% ROIBLLNBilliontoone12/1/2025Initiated Coverage$130.18$150.00Overweight$0.0000.00% ROINTRANatera11/25/2025Boost Price Target$238.11$250.00Overweight$0.0000.00% ROIAAgilent Technologies11/25/2025Boost Price Target$155.81$180.00Overweight$0.0000.00% ROITXG10x Genomics11/7/2025Boost Price Target$14.87$15.00Neutral$0.0000.00% ROITrump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.See which companies control the supply chain behind this emerging techQDELQuidelOrtho11/7/2025Lower Price Target$20.32$22.00Underweight$0.0000.00% ROINTRANatera11/7/2025Boost Price Target$199.63$240.00Overweight$0.0000.00% ROICRLCharles River Laboratories International11/6/2025Boost Price Target$170.82$165.00Neutral$0.0000.00% ROISHCSotera Health11/5/2025Boost Price Target$16.14$16.00Neutral$0.0000.00% ROIILMNIllumina10/31/2025Boost Price Target$121.46$105.00Neutral$0.0000.00% ROIIQVIQVIA10/29/2025Boost Price Target$219.81$255.00Overweight$0.0000.00% ROIHOLXHologic10/22/2025Reiterated Rating$73.98$78.00Neutral$0.0000.00% ROIAAgilent Technologies10/9/2025Boost Price Target$140.81$165.00Overweight$0.0000.00% ROIMTDMettler-Toledo International10/9/2025Boost Price Target$1,328.52$1,285.00Neutral$0.0000.00% ROIWATWaters10/9/2025Boost Price Target$328.36$325.00Neutral$0.0000.00% ROITMOThermo Fisher Scientific10/9/2025Boost Price Target$536.70$650.00Overweight$0.0000.00% ROIGHGuardant Health9/25/2025Boost Price Target$57.67$70.00Overweight$0.0000.00% ROICRLCharles River Laboratories International8/7/2025Boost Price Target$150.12$160.00Neutral$0.0000.00% ROIICLRIcon4/29/2025Downgrade$145.00$150.00Neutral$000.0000.00% ROIQDELQuidelOrtho4/21/2025Lower Price Target$24.35$25.00Underweight$00.0000.00% ROICRLCharles River Laboratories International2/20/2025Lower Price Target$164.90$165.00Neutral$000.0000.00% ROIICLRIcon2/3/2025Lower Price Target$195.96$265.00Overweight$000.0000.00% ROICRLCharles River Laboratories International2/3/2025Lower Price Target$161.46$175.00Neutral$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenJefferies Financial GroupUBS GroupThe Goldman Sachs GroupWeiss RatingsCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.TD CowenTruist FinancialPiper SandlerDeutsche Bank Aktiengesellschaft Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
